Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: the Australian Study for the …
… ) to be conducted to test whether vaccination with the pneumococcal polysaccharide vaccine
will reduce cardiovascular events. If successful, vaccination can be readily extended to at-…
will reduce cardiovascular events. If successful, vaccination can be readily extended to at-…
Rational design of conjugate vaccines
RZ Dintzis - Pediatric research, 1992 - nature.com
… in children vaccinated with type b polysaccharide vaccine. N … b polysaccharide-outer
membrane protein conjugate vaccine … previous vaccination with type b polysaccharide vaccine. J …
membrane protein conjugate vaccine … previous vaccination with type b polysaccharide vaccine. J …
… controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and design
CJ Acosta, CM Galindo, M Ali… - Tropical Medicine & …, 2005 - Wiley Online Library
… Here we describe the rationale and design behind the … Vi polysaccharide (PS) vaccine
and present preliminary results of the pilot phase that guided decisions in the final study design …
and present preliminary results of the pilot phase that guided decisions in the final study design …
[PDF][PDF] Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults
E Hak, DE Grobbee, EA Sanders, TJ Verheij… - Neth J Med, 2008 - academia.edu
… Although the 23-valent polysaccharide pneumococcal vaccine (23vPs) is considered
effective in the prevention of invasive pneumococcal disease in the elderly population, the …
effective in the prevention of invasive pneumococcal disease in the elderly population, the …
Polysaccharide vaccines
R Austrian - Annales de l'Institut Pasteur/Microbiologie, 1985 - Elsevier
… of the failure of many to perceive that the aggregate efficacy ef a vaccine designed to
prevent 23 immunologieally distinct infections is unlikely ever to equal that of a monovalent …
prevent 23 immunologieally distinct infections is unlikely ever to equal that of a monovalent …
Polysaccharides and glycoconjugates as human vaccines
HJ Jennings, RA Pon - Polysaccharides in medicinal applications, 2017 - taylorfrancis.com
… polysaccharides, and this led to the formulation of a 23-valent polysaccharide vaccine which
remains the current vaccine … of the polysaccharides used in the current vaccine are shown …
remains the current vaccine … of the polysaccharides used in the current vaccine are shown …
[PDF][PDF] Vaccine technologies & the rationale for new nanoparticle formulations
RS Becker - Drug Development & Delivery, 2014 - lubrizolcdmo.com
… The liposomes have been designed in some applications to contain and deliver vaccine …
antigen-specific B lymphocytes a means to bind the polysaccharide via their antibody and …
antigen-specific B lymphocytes a means to bind the polysaccharide via their antibody and …
Vaccine design in the 21st century
MJ Bottomley, R Rappuoli, O Finco - The vaccine book, 2016 - Elsevier
… Such vaccines were based on the use of capsular polysaccharide (CPS) preparations …
underlying polysaccharide vaccine-induced immunity. However, plain polysaccharide vaccines …
underlying polysaccharide vaccine-induced immunity. However, plain polysaccharide vaccines …
Mucosal vaccine design and delivery
KA Woodrow, KM Bennett, DD Lo - Annual review of biomedical …, 2012 - annualreviews.org
… For example, the meningococcal unconjugated polysaccharide vaccine given in young
children leads to a significant ELISA-detectable antibody binding response but provides poor …
children leads to a significant ELISA-detectable antibody binding response but provides poor …
Capsular polysaccharides as vaccine candidates
HJ Jennings - Bacterial Capsules, 1990 - Springer
… A promising area of research to overcome the deficiency of polysaccharide vaccines in
infants is the design of a new generation of semisynthetic vaccines based on the conjugation (…
infants is the design of a new generation of semisynthetic vaccines based on the conjugation (…
相关搜索
- pneumococcal polysaccharide vaccine rationale and design
- polysaccharide typhoid vaccine rationale and design
- 23 valent pneumococcal polysaccharide vaccine
- vaccine efficacy rationale and design
- bacterial polysaccharide vaccines
- capsular polysaccharide vaccine
- capamis study rationale and design
- pneumococcal polysaccharide vaccine randomised controlled trial
- polysaccharide vaccine south western china
- polysaccharide vaccine prevention of cardiovascular events
- pneumococcal polysaccharide vaccine australian study
- pneumococcal polysaccharide vaccine elderly japanese adults
- polysaccharide vaccine comparison of meta analyses
- pneumococcal polysaccharide vaccine immunogenicity and safety
- effectiveness evaluation rationale and design
- pneumococcal polysaccharide vaccine clinical effectiveness